C07K 16/081
Dna viruses
Official title: DNA viruses
C07K16/081 (Dna viruses) appears on 707 US grants and 1,017 published applications in this corpus.
Search patents in C07K- Granted patents
- 707
- Published applications
- 1,017
- Assignees
- 598
- Inventors
- 2,115
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1977 | 1 | 0 |
| 1978 | 1 | 0 |
| 1979 | 0 | 0 |
| 1980 | 2 | 0 |
| 1981 | 1 | 0 |
| 1982 | 1 | 0 |
| 1983 | 0 | 0 |
| 1984 | 2 | 0 |
| 1985 | 0 | 0 |
| 1986 | 2 | 0 |
| 1987 | 4 | 0 |
| 1988 | 8 | 0 |
| 1989 | 9 | 0 |
| 1990 | 3 | 0 |
| 1991 | 3 | 0 |
| 1992 | 10 | 0 |
| 1993 | 10 | 0 |
| 1994 | 2 | 0 |
| 1995 | 8 | 0 |
| 1996 | 12 | 0 |
| 1997 | 14 | 0 |
| 1998 | 19 | 0 |
| 1999 | 12 | 0 |
| 2000 | 18 | 0 |
| 2001 | 16 | 3 |
| 2002 | 10 | 16 |
| 2003 | 17 | 26 |
| 2004 | 5 | 26 |
| 2005 | 10 | 25 |
| 2006 | 19 | 29 |
| 2007 | 11 | 28 |
| 2008 | 18 | 23 |
| 2009 | 7 | 21 |
| 2010 | 15 | 36 |
| 2011 | 16 | 27 |
| 2012 | 26 | 37 |
| 2013 | 19 | 42 |
| 2014 | 30 | 43 |
| 2015 | 17 | 48 |
| 2016 | 25 | 47 |
| 2017 | 34 | 31 |
| 2018 | 30 | 60 |
| 2019 | 37 | 53 |
| 2020 | 35 | 52 |
| 2021 | 27 | 67 |
| 2022 | 28 | 55 |
| 2023 | 24 | 68 |
| 2024 | 29 | 64 |
| 2025 | 36 | 51 |
| 2026 | 24 | 39 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Compositions and methods related to human neutralizing antibodies to hepatitis B29 Sep 2026US 12,747,283 B2The Rockefeller University
- Engineered immunoglobulins with altered FcRn binding7 Jul 2026US 12,674,004 B2Universitetet I Oslo
- Neutralizing monoclonal anti-VP1 antibodies to BK virus30 Jun 2026US 12,668,620 B2Icahn School of Medicine at Mount Sinai
- Antigen binding polypeptides, antigen binding polypeptide complexes and methods of use thereof30 Jun 2026US 12,668,645 B2ModeX Therapeutics, Inc.
- Polyomavirus neutralizing antibodies16 Jun 2026US 12,653,885 B2Novartis AG
- Compositions and methods for treatment of neurological disorders8 Oct 2026US 2026/0308614 A1Board of Regents, The University of Texas System
- Methods and compositions comprising purified recombinant polypeptides1 Oct 2026US 2026/0297179 A1Genentech, Inc.
- Antigen binding polypeptides, antigen binding polypeptide complexes and methods of use thereof17 Sep 2026US 2026/0274995 A1ModeX Therapeutics, Inc.
- Aav9 capsid variants escaping neutralizing human antibodies10 Sep 2026US 2026/0265308 A1University of Florida Research Foundation, Inc.
- Recombinant polyclonal proteins targeting hepatitis b virus (hbv) and methods of use thereof10 Sep 2026US 2026/0265345 A1GigaGen, Inc.
Most cited
By later US patents
- Humanized immunoglobulins2,884US 5,585,089 AProtein Design Labs, Inc. · 1996
- Humanized immunoglobulins2,259US 5,530,101 AProtein Design Labs, Inc. · 1996
- Humanized immunoglobulins2,030US 5,693,762 AProtein Design Labs, Inc. · 1997
- Humanized immunoglobulins and methods of making the same1,467US 6,180,370 B2Protein Design Labs, Inc. · 2001
- Polynucleotides encoding improved humanized immunoglobulins1,258US 5,693,761 AProtein Design Labs, Inc. · 1997